Addgene: Homepage

“Addgene is a global, nonprofit repository that was created to help scientists share plasmids. Plasmids are DNA-based research reagents commonly used in the life sciences. When scientists publish research papers, they deposit their associated plasmids at Addgene. Then, when other scientists read the publication, they have easy access to the plasmids needed to conduct future experiments. Before Addgene, scientists were tasked with repeatedly shipping plasmids to each new requesting scientist. Now, scientists ship their plasmids to Addgene once, and we take care of the quality control, MTA compliance, shipping, and record-keeping.

For scientists looking to use plasmids, Addgene provides a searchable database of high-quality plasmids, pooled libraries, and plasmid kits, available at affordable prices. All plasmids in Addgene’s repository are sequenced for quality control purposes and tracked with barcodes from the time they arrive at our facility until they are packed for shipment. Scientists can request plasmids through Addgene’s online ordering system. As of 2016, Addgene also provides ready-to-use AAV and lentivirus preparations of commonly requested plasmids as a service to scientists….”

Therapoid, from Open Therapeutics

“Open Therapeutics™ facilitates and enables collaboration among life science researchers around the world!


There are highly qualified scientists everywhere. They want to collaborate. However, there is no comprehensive platform for them to do so – until now!


The Open Therapeutics’ Therapoid™ scientific ecosystem enables much more than just collaboration.


As a web platform for scientific collaboration Therapoid includes:


Open biotechnologies for advancing research and gaining publications,

Funding to further develop open biotechnologies,

An asset exchange that hosts freely available equipment and supplies,

A manuscript development process,

A preprint server for hosting manuscripts.

Goals of Open Therapeutics’ include lowering biotechnology and pharmaceutical costs, reducing the risks and time to develop life-saving therapies, and broadening markets for therapeutics, particularly for underserved populations around the world.”

Open Therapeutics

“Open Therapeutics™ facilitates biopharma developments by enabling capable and responsible researchers around the world to collaborate. Open Therapeutics has two components: (i) an open web platform for scientific collaboration known as Therapoid™, and (ii) open biotechnologies for rapid prototyping of therapeutics.

Open Therapeutics™ enables open access, open collaboration, rapid prototyping, meritocracy, and community. The goal is to lower costs, reduce risks and time, and broaden markets for therapeutics.

The Therapoid™ web portal enables international scientists to share research easily, while it also opens a path to develop dormant technologies. Simple to use tools enable more effective collaboration. The combination of collaboration and biotechnologies will lead to better therapeutics for patients in every country….”

How biologists pioneered preprints—with paper and postage | Science

Abstract:  As a growing number of biologists formally share their papers in online repositories, it’s often said that they are catching up with physicists, who have posted preprints in the online arXiv server since 1991. But biomedical scientists were actually first, reveals a researcher who has traced a “forgotten experiment” from the 1960s, when the National Institutes of Health (NIH) in Bethesda, Maryland, created a preprint exchange but shut it down when publishers objected. Matthew Cobb, a biologist and science historian at the University of Manchester in the United Kingdom, recounts how starting in 1961, a 70-year-old NIH administrator named Errett Albritton formed what he called information exchange groups, consisting of interested scientists working in the same subfield.

F1000Research – An innovative open access publishing platform offering immediate publication and open peer review.

“F1000Research is an Open Research publishing platform offering immediate publication of articles and other research outputs with no editorial bias. All articles benefit from transparent peer review and the inclusion of all source data….The traditional anonymous pre-publication peer review of research articles can cause long delays before new results become visible. F1000Research uses an author-led process, publishing all scientific research within a few days. Open, invited peer review of articles is conducted after publication, focusing on scientific soundness rather than novelty or impact….”

Human genome data ‘should be open to all’

“A leading genomic scientist has called on people who have their DNA analysed to make the full results openly available “for the greater public good”. …While conceding that “open access to genome sequences is not for everyone”, he hoped that many people would donate their genomes openly to science once they understood the risks and benefits….”

Winners announced for the BMC Ecology Image Competition 2017 | EurekAlert! Science News

“From close-ups that capture the animated life of insects, to aerial views of vast landscapes, the 2017 BMC Ecology Image Competition has produced a terrific array of images that reflect the variety of research in progress in the field. All images are open access and available under a Creative Commons Attribution 4.0 license.”

New tool could standardize the process of sharing research materials – Tech Transfer e-News – Tech Transfer Central

“Developed by the UK OpenPlant Synthetic Biology Research Centre and the BioBricks Foundation, OpenMTA honors the rights of researchers and promotes safe, responsible laboratory practices. In addition, the tool is designed to work within the practical realm of tech transfer and to be adaptable to the needs of multiple groups globally.

Goals for OpenMTA include:

  • Free access to the tool, with no royalties or other fees except for appropriate and nominal fees for preparation and distribution;
  • The ability for researchers to modify or repurpose materials available through OpenMTA;
  • Unrestricted selling and sharing of materials, whether it’s part of a collaboration or derivative work;
  • Availability to all kinds of institutions including academic, industrial, federal and community research centers

In its approach to tech transfer, Open MTA is designed to reduce transaction costs, support research collaboration across institutions and even nations, and provide a way for researchers and their labs to be credited for the materials they share.”

Sharing Is Daring | Stanford Social Innovation Review

“The sequence of the human genome, completed in 2001, was supposed to quickly reveal the secrets of health and disease. Instead, it showed that human bodies are more complicated than anyone realized. Disease is usually caused not by one bad gene, but by subtle variations in dozens or hundreds of genes working with and against each other in vast networks.

This discovery delivered a reality check to genome scientist Eric Schadt. Pharmaceutical giant Merck had spent hundreds of millions of dollars…”